Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

As of 24 Sep 2026, Alkem Laboratories Ltd’s stock price closed at ₹5,414.15, marking a 1.44% increase from the previous close of ₹5,337.15. The intraday range saw a low of ₹5,313.60 and a high of ₹5,434.45, indicating moderate volatility within a relatively narrow band. The stock remains below its 52-week high of ₹5,933.00 but comfortably above the 52-week low of ₹5,052.05, reflecting a resilient price base amid sectoral headwinds.

The technical trend has shifted from bearish to mildly bearish, signalling a potential easing of downward pressure. This is corroborated by the monthly MACD and Bollinger Bands indicators, which have improved to mildly bearish and bullish respectively, while weekly indicators remain more cautious with bearish readings. The daily moving averages continue to reflect bearish momentum, suggesting that short-term price action remains under pressure despite some medium-term improvement.

MACD and Momentum Analysis

The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD remains bearish, indicating that the stock’s momentum is still subdued in the near term. However, the monthly MACD has improved to mildly bearish, hinting at a possible bottoming out or a gradual shift towards positive momentum over the coming months. This divergence between weekly and monthly MACD readings suggests that while short-term traders may remain cautious, longer-term investors could find emerging opportunities as the momentum stabilises.

RSI and Overbought/Oversold Conditions

The Relative Strength Index (RSI) on a monthly timeframe has turned bullish, signalling that the stock is gaining strength and may be moving out of oversold territory. Conversely, the weekly RSI shows no clear signal, indicating a neutral stance in the short term. This disparity reinforces the notion of a stock in transition, where medium-term strength is building but short-term volatility and indecision persist.

Bollinger Bands and Volatility Insights

Bollinger Bands provide further insight into the stock’s volatility and price range. The weekly Bollinger Bands remain bearish, suggesting that the stock price is still trading near the lower band and may face resistance in the short term. In contrast, the monthly Bollinger Bands have turned bullish, implying that the stock is beginning to trade closer to the upper band on a longer timeframe, which could indicate a gradual increase in buying interest and reduced volatility.

Moving Averages and Trend Confirmation

Daily moving averages continue to signal bearish momentum, reflecting that the stock price remains below key short-term averages such as the 20-day and 50-day moving averages. This suggests that despite recent gains, the stock has yet to confirm a sustained uptrend in the near term. The weekly and monthly KST (Know Sure Thing) indicators align with this view, remaining bearish and mildly bearish respectively, indicating that momentum is still fragile but showing signs of improvement.

Volume and Dow Theory Signals

Volume-based indicators such as On-Balance Volume (OBV) show no clear trend on a weekly basis but have turned mildly bullish on a monthly scale. This suggests that accumulation may be occurring gradually, supporting the case for a potential medium-term recovery. Dow Theory analysis reveals no definitive trend weekly but mildly bearish conditions monthly, reinforcing the cautious tone of the technical outlook.

Comparative Performance and Market Context

Alkem Laboratories Ltd’s recent returns outperform the broader Sensex benchmark over several periods. The stock posted a 4.34% gain over the past week compared to Sensex’s 0.66%, and a modest 0.31% increase over the last month versus a 3.50% decline in the Sensex. Year-to-date, Alkem has declined by 1.65%, significantly outperforming the Sensex’s 12.19% fall. Over longer horizons, the stock has delivered robust returns, with a 52.74% gain over three years and an impressive 207.83% over ten years, well ahead of the Sensex’s 161.01% in the same period.

These figures highlight Alkem’s resilience and relative strength within the Pharmaceuticals & Biotechnology sector, which has faced headwinds amid regulatory and pricing pressures. The company’s mid-cap status and a Mojo Score of 50.0, upgraded from a previous Sell to a Hold rating on 18 Sep 2026, reflect a balanced view of its prospects amid evolving market conditions.

Investment Implications and Outlook

For investors, the technical signals from Alkem Laboratories Ltd suggest a cautious but improving outlook. The shift from outright bearishness to mildly bearish and bullish signals on monthly indicators implies that the stock may be entering a phase of consolidation or early recovery. However, the persistence of bearish daily moving averages and weekly momentum indicators advises prudence, as short-term volatility and resistance levels remain relevant.

Given the stock’s relative outperformance against the Sensex and its strong long-term returns, Alkem remains a noteworthy contender within the Pharmaceuticals & Biotechnology sector. The upgrade in Mojo Grade from Sell to Hold further supports a neutral stance, recommending investors to monitor technical developments closely before committing to significant positions.

In summary, Alkem Laboratories Ltd’s technical momentum is signalling a tentative shift towards stability, with mixed signals across timeframes highlighting the need for a balanced approach. Investors should weigh these technical insights alongside fundamental factors and sector dynamics to make informed decisions in the current market environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →